Semaglutide studies: 1,194 papers with results
Page 19 of 24
- A Case Report of Bezoar-Induced Small Bowel Obstruction: A Potential Surgical Complication of Semaglutide.
Keng C · Cureus · 2025
Case report or series · 1 result
- Short-Term Semaglutide Improves Safety in High Body Weight Recipients Undergoing Living Donor Liver Transplant: A Case Report.
Cheng SM · Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation · 2025
Case report or series · 3 results
- Coincidence of Autoimmune Diabetes Mellitus and Familial Partial Lipodystrophy.
Krienke M · JCEM case reports · 2025
Case report or series · 2 results
- Larotrectinib-associated withdrawal symptoms resolved following initiation of GLP-1 receptor agonist: a case report.
Patel R · Cancer chemotherapy and pharmacology · 2025
Case report or series · 1 result
- Bariatric surgery and semaglutide in a youth with juvenile Huntington disease and severe obesity: a case report.
Vidmar AP · Journal of medical case reports · 2025
Case report or series · 6 results
- Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women.
Mohammed A · AACE endocrinology and diabetes · 2026
Case report or series · 6 results
- Semaglutide in the treatment of a patient with type 2 diabetes mellitus, psoriasis, and metabolic dysfunction-associated steatotic liver disease: a case report.
Lin B · Frontiers in medicine · 2025
Case report or series · 5 results
- Semaglutide as a potential therapeutic adjunct for reducing flare-ups in Sjögren's syndrome: A case report.
Jung J · SAGE open medical case reports · 2025
Case report or series · 2 results
- Oral Semaglutide Further Reduced LDL Cholesterol in a Patient with Familial Hypercholesterolemia Treated with Statins, Ezetimibe, and Evolocumab.
Tada H · Internal medicine (Tokyo, Japan) · 2026
Case report or series · 2 results
- Subjective Olfactory Impairment in a Patient Undergoing Anti-Obesity Pharmacotherapy: A Case of Symptom-Test Discrepancy.
Lee HJ · Life (Basel, Switzerland) · 2025
Case report or series · 3 results
- Neuropsychiatric side effects of semaglutide in patients with dementia.
Jamshed N · BMJ case reports · 2025
Case report or series · 3 results
- Sustained Effects of Glucagon-Like Peptide-1 (GLP-1) Agonists on Blood Pressure in Obesity and Type 2 Diabetes: A Longitudinal Case Study.
Joseph J · Cureus · 2025
Case report or series · 4 results
- Type 2 Diabetes in a 4-Year-Old With Obesity: Considerations for Use of Semaglutide and Bariatric Surgery in Children.
Connard J · JCEM case reports · 2025
Case report or series · 2 results
- Semaglutide therapy and iatrogenic thyrotoxicosis.
Barnett MJL · Endocrinology, diabetes & metabolism case reports · 2025
Case report or series · 3 results
- Effect of Ozempic on Diabetic Nephropathy: A Case Report.
Joseph J · Cureus · 2025
Case report or series · 3 results
- Increased Weight Loss With the Combination of Levoketoconazole and Semaglutide in a Patient With Mild Hypercortisolism.
Kargutkar S · AACE endocrinology and diabetes · 2025
Case report or series · 3 results
- Type 2 Diabetes Mellitus Diagnosed at the Age of Eight Years: A Case Report.
Hasan MR · Cureus · 2025
Case report or series · 4 results
- Semaglutide treatment for type 2 diabetes in a patient with chronic myeloid leukemia: A case report and review of the literature.
Zhang Y · Open medicine (Warsaw, Poland) · 2025
Case report or series · 6 results
- Asymptomatic Subcutaneous Semaglutide Overdose: A Case Report and Literature Review.
Diec CB · Journal of pharmacy practice · 2026
Case report or series · 7 results
- Semaglutide reverses the chronic myopathy of hyperkalemic periodic paralysis: a case report.
Brand K · BMC nephrology · 2025
Case report or series · 2 results
- Acute Duodenal Ulcer Perforation Following Tirzepatide Treatment: A Case Report.
Hayashi M · Cureus · 2025
Case report or series · 3 results
- Achieving Over 30% Body Weight Loss With Semaglutide in a Patient: A Case Report.
Danish S · Cureus · 2025
Case report or series · 4 results
- The Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Acute Cholecystitis After a Routine Colonoscopy: A Case Report.
Abdulraheem A · Cureus · 2025
Case report or series · 1 result
- Refractory Dysmenorrhea Managed With a Glucagon-Like Peptide-1 Agonist: A Case Report.
Tran M · Cureus · 2025
Case report or series · 4 results
- Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults.
Khan AR · Endocrine regulations · 2025
Case report or series · 1 result
- Pharmacologic Management of Obesity in Neuro-Oncology: A Case Report.
Lardieri A · Case reports in oncology · 2025
Case report or series · 2 results
- Effects of GLP1 receptor analogues in obesity with neurodevelopmental disorder: case report of a patient with holoprosencephaly.
Le Guiniec M · European journal of clinical nutrition · 2024
Case report or series · 3 results
- Semaglutide as a potential treatment for obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report.
Bonnet JB · Obesity research & clinical practice · 2024
Case report or series · 2 results
- Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide.
Ahern S · Cureus · 2025
Case report or series · 4 results
- An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg.
Pratley RE · Diabetes, obesity & metabolism · 2021
Other design · 8 results
- Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist.
Buckley ST · Science translational medicine · 2018
Other design · 10 results
- Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes.
Overgaard RV · Cell reports. Medicine · 2021
Other design · 5 results
- Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison.
Michalak W · Diabetes, obesity & metabolism · 2026
Other design · 7 results
- Semaglutide 25 mg Oral Versus Semaglutide 2.4 mg Injectable: An Indirect Treatment Comparison of Weight Loss Outcomes.
Plotkin M · Diabetes, obesity & metabolism · 2026
Other design · 5 results
- Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.
Zhang L · Journal of Parkinson's disease · 2019
Animal study (in vivo) · mouse · 16 results
- The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists.
Urva S · Diabetes, obesity & metabolism · 2020
Animal study (in vivo) · mouse · 9 results
- Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide.
Basalay MV · Cardiovascular drugs and therapy · 2019
Animal study (in vivo) · rat · 8 results
- The human GLP-1 analogs liraglutide and semaglutide: absence of histopathological effects on the pancreas in nonhuman primates.
Gotfredsen CF · Diabetes · 2014
Animal study (in vivo) · cynomolgus monkey · 11 results
- The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron.
Sloop KW · Science translational medicine · 2024
Animal study (in vivo) · rat · 11 results
- Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression.
Marathe SJ · npj metabolic health and disease · 2025
Animal study (in vivo) · mouse · 16 results
- A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance.
Ludwig MQ · Nature metabolism · 2026
Animal study (in vivo) · rat · 6 results
- Generation and characterisation of a humanised GLP-1 receptor mouse model for translational drug development.
Sonne N · EBioMedicine · 2026
Animal study (in vivo) · mouse · 18 results
- Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet-induced Mouse Model.
Xia H · Radiology · 2025
Animal study (in vivo) · mouse · 11 results
- Identification and utility exploration of a highly potent and long-acting bullfrog GLP-1 analogue in GLP-1 and amylin combination therapy.
Sun X · Peptides · 2024
Animal study (in vivo) · mouse · 7 results
- Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction.
Levi O · Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
Animal study (in vivo) · rat · 7 results
- Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in male and female rats.
Windram M · Psychopharmacology · 2026
Animal study (in vivo) · rat · 5 results
- Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison.
Hitaka K · International journal of obesity (2005) · 2026
Animal study (in vivo) · mouse · 37 results
- Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice.
Ding M · iScience · 2026
Animal study (in vivo) · mouse · 9 results
- A biodegradable suction patch for sustainable transbuccal peptide delivery
Krupke H · Journal of Controlled Release · 2025
Animal study (in vivo) · beagle dog · 2 results
- Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity
John L · Journal of the Endocrine Society · 2021
Animal study (in vivo) · mouse and rat · 18 results